logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yang Cao

tongji medical college
H指数:27
被引数:3,127

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic HCT

移植前后TP53分子微小残留病作为TP53突变AML/MDS接受异基因造血干细胞移植患者复发的预后生物标志物

Blood Cancer Journal
IF11.6
2026-06-260
OAAI
Yeqian Zhao; Weijie Cao; Jimin Shi; Yiqiu Zheng; Yi Luo; Jian Yu; Lizhen Liu; Xiaoyu Lai; Huarui Fu; Congxiao Zhang; Yi Yu; Yishan Ye; Jiehan Liang; Xin Huang; Yang Cao; Wei Shi; Xiaoxia Hu; He Huang; Yanmin Zhao
Changing donors improves outcomes of second transplantation inpatients who experienced graft failure after first allogeneic stem cell transplantation

Ma, R.; Zhu, X.Y.; Lu, Y.; Chen, J.; Xuan, L.; Yuan, H.L.; Cao, Y.; Cao, W.J.; Fang, X.S.; Miao, K.R.; 等. 更换供者可改善首次异基因造血干细胞移植后发生移植物衰竭患者的二次移植结局。Haematologica, 2026; 在印刷中。 [Google Scholar] [CrossRef]

Haematologica
IF7.9
2026-02-012
OAAI
Ma, Rui; Zhu, Xiao-Yu; Lu, Yue; Chen, Jia; Xuan, Li; Yuan, Hai-Long; Cao, Yang; Cao, Wei-Jie; Fang, Xiao-Sheng; Miao, Kou-Rong; Hu, Xiao-Xia; Yi, Hai; Zhao, Yan-Min; Wu, Yuan-Bin; Yang, Ting; Wang, Hong-Tao; Yin, Yue; Zhang, Zhong-Ming; Zhang, Xiao-Hui; Xu, Lan-Ping; Wang, Yu; Liu, Kai-Yan; Huang, Xiao-Jun; Sun, Yu-Qian
Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

所有道路都通往罗马吗？在新靶向药物时代，获得治疗反应并接受自体干细胞移植的复发/难治性弥漫大B细胞淋巴瘤患者的异质性。

Cell Transplantation
IF3.2
2025-12-150
OA
Jiangtao Li; Wenxuan Huo; Yang Yang; Chunli Zhang; Fengrong Wang; Shengye Lu; Ru Feng; Yang Liu; Leqing Cao; Gaoxiang Wang; Hui Liu; Jihao Zhou; Yang Cao; Xiaodong Mo
Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

异基因造血干细胞移植后骨髓纤维化患者的移植物失败发生率和危险因素

BONE MARROW TRANSPLANTATION
IF5.2
2025-11-010
PRE
Sun, Yuqian; Zhu, Jun; Chen, Jia; Jiang, Erlie; Tang, Borui; Chen, Xinchuan; Zhao, Yanmin; Shi, Wei; Zhang, Xi; Zhou, Fang; Zhao, Mingfeng; Yan, Jinsong; Tan, Yehui; Xu, Shuangnian; Bai, Guanchen; Cao, Weijie; Cao, Yang; Fei, Xinhong; Zhou, Jian; Wang, Sanbin; Zhao, Peng; Miao, Kourong; Lu, Ying; Ding, Li; Yan, Zhiling; Dou, Liping; Lan, Mei; Wang, Shunqing; Wang, Zhiguo; Yi, Hai; Yuan, Hailong; Fang, Xiaosheng; Zhang, Hao; Huang, Xiaojun
Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients

由细胞介导的巨细胞病毒免疫力指导的来特莫韦预防可改善异基因造血干细胞移植受者的结局

CLINICAL INFECTIOUS DISEASES
IF7.3
2025-08-013
PRE
Wang, Luxiang; Huang, Jingtao; Jiang, Chuanhe; Huang, Meijuan; Guo, Xiaojia; Li, Su; Zhang, Zilu; Huang, Jiayu; Lu, Haiyang; Pan, Zengkai; Zhu, Jun; Chen, Qi; He, Yang; Cao, Yang; Hu, Xiaoxia
Impact of TP53 variants and germline mutations on allogeneic stem cell transplantation outcomes in acute myeloid leukemia and myelodysplastic neoplasms

TP53变异和胚系突变对急性髓系白血病和骨髓增生异常肿瘤异基因造血干细胞移植结局的影响

Leukemia
IF13.4
2025-07-140
PRE
Yeqian Zhao; Weijie Cao; Jimin Shi; Yang Cao; Ying Lu; Yi Luo; Guifang Ouyang; Lieguang Chen; Jianping Lan; Xiaolu Song; Yi Chen; Li Yu; Jian Yu; Xiaoyu Lai; Lizhen Liu; Huarui Fu; Yishan Ye; Luxin Yang; Xiaodong Mo; Xiaoxia Hu; He Huang; Yanmin Zhao
Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fl udarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma
CYTOTHERAPY
IF3.2
2024-05-011
OAAI
Xin, Xiangke; Lin, Li; Yang, Yang; Wang, Na; Wang, Jue; Xu, Jinhuan; Wei, Jia; Huang, Liang; Zheng, Miao; Xiao, Yi; Meng, Fankai; Cao, Yang; Zhu, Xiaojian; Zhang, Yicheng
Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide

重组人血小板生成素促进重型再生障碍性贫血患者单倍体造血干细胞移植后改良环磷酰胺治疗后血小板植入

TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2024-05-015
PRE
Fu, Andie; Peng, Yizhou; Cheng, Ping; Wu, Jiaying; Zhu, Xiaojian; Yang, Yang; Huang, Lifang; Wang, Na; Wang, Jue; Xu, Jinhuan; Wan, Yuling; Cao, Yang; Wei, Jia; Xiao, Yi; Meng, Fankai; Cheng, Hui; Zhang, Yicheng; Zhang, Donghua

研究方向

暂未获取到该数据
J
Jianfeng Zhou
H 指数:63论文数:591被引数:1.6万
L
Liang Huang
H 指数:46论文数:498被引数:8,520
张意成 封面图
张意成
H 指数:22论文数:324被引数:2,126
王珏 封面图
王珏
H 指数:48论文数:403被引数:7,441
王
王娜
H 指数:25论文数:160被引数:3,129
F
Fankai Meng
H 指数:22论文数:117被引数:2,246
L
Liting Chen
H 指数:35论文数:290被引数:5,052
C
Chunrui Li
H 指数:32论文数:259被引数:4,055
G
Gaoxiang Wang
H 指数:20论文数:97被引数:2,972
M
Min Xiao
H 指数:49论文数:484被引数:9,228